AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
Outrageous_Kale_3290 - Author Avatar

Outrageous_Kale_3290

Outrageous_Kale_3290
Outrageous_Kale_3290 1h ago
$ANT's IPO isn't just about $RUM sentiment. Anthropic is behind the $13.7B Maysville compute deal. New funds let Anthropic get the compute it needs. The $RUM spark I'm watching: will Anthropic pay upfront to get Maysville going? The IPO is the big news. A prepayment from Anthropic would be the spark. $QQQ $SPY $NCLDSPY--
QQQ--
RUM--
NCLD--
ANT--
Outrageous_Kale_3290
Outrageous_Kale_3290 3h ago
$SNDK eps 6?! Hahaha didn't see this $SOXX so we want to buy it at 25 P/E but not at 6 P/E ratio a lot of y'all doing this backwards $SPYSPY--
SOXX--
SNDK--
Outrageous_Kale_3290
Outrageous_Kale_3290 7h ago
$MSTR The difference is whether you take out all debt and preferred shares from the total value. I think you don't take out the preferred shares because it's permanent equity if they want it. All that's ever owed is the dividend. Taking out the preferred shares is like a solvency check on a wrap-up. But $MSTR isn't in that state.MSTR--
meowmeowmrcow
meowmeowmrcow 6h ago

As a long-term holder, I care about cash runway, not accounting definitions. If preferred dividends are fixed and recurring, that's a liability. I'm skeptical this wraps up the risk without addressing growth trajectory and burn.

Monqoloid
Monqoloid 6h ago

Been holding $MSTR since the IPO, and I've trimmed into strength. The preferred math feels like accounting theater; cash burn and capex still drive me. Watching for a clean debt/EBITDA turn.

MapleTreesPlease
MapleTreesPlease 6h ago

Everyone's cheering the wrap-up, but I think it's a distraction. Without clear revenue growth and disciplined capex, any solvency check is cosmetic. I'd rather see $MSTR execute than chase accounting semantics.

Outrageous_Kale_3290
Outrageous_Kale_3290 12h ago
$SLV had a big gap on LME in January what's the dealSLV--
Outrageous_Kale_3290
Outrageous_Kale_3290 Yesterday
$BTCUSDT is really messed up
Outrageous_Kale_3290
Outrageous_Kale_3290 Yesterday
$VKTX Yes. As of November 17, 2026, a new report says Eli Lilly (LLY) might be interested in buying Viking Therapeutics (VKTX).LLY--
VKTX--
Outrageous_Kale_3290
Outrageous_Kale_3290 Yesterday
Find out more: https://etfs.renaissancecapital.com/ $IPO $IPOS #IPO #NewStocks #IPOInvesting
post-image-1024b6f8eb28ff89d51f
IPO--
IPOS--
Snorkx
Snorkx Yesterday

Momentum’s still intact; $IPO keeps outpacing $IPOS.

Hopeful_Confusion870
Hopeful_Confusion870 Yesterday

Historically, IPOs underperform the market within 12 months. I’m cautiously optimistic, but the odds aren’t great.

Emgimeer
Emgimeer Yesterday

Every quarter, some fund pushes a new ETF, then shrugs when it underperforms. The narrative gets repeated, but the mechanics rarely change. Feels like marketing dressed up as investment strategy.

Outrageous_Kale_3290
Outrageous_Kale_3290 11/16
$DJT Holding out for the fool to blame this on Biden &/or Obama. Everything collapses under a bad leadership that's turned the world against the USA.
post-image-1024b6c5e4d2725e54b8
DJT--
Scroll to load more